Ugur Sahin

Ugur Sahin (#1093)

Global Rank #1093

Country Rank #70

Country Germany

Ugur Sahin is listed among the world billionaires tracked by Iconic Billionaires.

$ 4 B
Biotechnology
Germany
M
60 Years

Snapshot

Quick Facts

Global Rank #1,093

Country Rank #70

Net Worth $3.9B

Previous Worth $4.0B

Worth Change -$0.1B

Country Germany

Industry Biotechnology

Age 60 Years

Gender M

Worth As Of May 4, 2026

Last Refreshed 26 Jul 2026, 12:00 AM

Residence Mainz, Germany

World Billionaires List Germany Billionaires Biotechnology

Profile Data

Personal Stats

Age 60

Source Of Wealth Biotechnology, Self Made

Residence Mainz, Germany

Citizenship Germany

Marital Status Married

Net Worth Change -$0.1B -2.5% from previous worth

Previous Net Worth $4.0B

Current Net Worth $3.9B

Worth as of May 4, 2026

About Me

Uğur Şahin is CEO and cofounder of German biotech firm BioNTech, which partnered with Pfizer to produce the first Covid-19 vaccine approved in the US. Şahin led BioNTech to start on a vaccine for the coronavirus in early 2020; it partnered with Pfizer in March 2020 and got approval in December. Şahin, who was born in Turkey and grew up in Germany, owns about 17% of BioNTech, which went public on the Nasdaq in October 2019. In 2001 Şahin and his immunologist wife, ?zlem T'reci, cofounded Ganymed Pharmaceuticals; Astellas Pharma acquired Ganymed in 2016 for $460 million. Şahin and his wife T'reci cofounded BioNTech in 2008, backed by German billionaire brothers Thomas and Andreas Struengmann.

Insights

Did You Know?

Sahin's parents worked in a Ford factory in Germany; he was trained as a doctor and worked as a researcher and a professor.

Germany's billionaire Struengmann brothers have backed both of Sahin's drug companies: Ganymed Pharmaceuticals and BioNTech SE.

Wealth Growth

Net Worth Growth Over Time

Tracking Ugur Sahin's net worth journey over the years, highlighting key growth phases and financial milestones.

Worth Trend Net Worth Growth

Period Change Worth Movement

Current Net Worth: $3.9B (May 4, 2026)